The 2016 Revision to the World Health Organization Classification of Myelodysplastic Syndromes

Affiliations

Ming Hong et al. J Transl Int Med. 2017.

. 2017 Sep 30;5(3):139-143.

doi: 10.1515/jtim-2017-0002. eCollection 2017 Sep.

¹ Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, Jiangsu Province, China.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors declare no conflict of interest.

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H. et al. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer. 2008:1–439.
1. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A. et al. The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–51. - PubMed
1. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G. et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–88. - PubMed
1. Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F. et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454–65. - PMC - PubMed
1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM. et al. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405. - PubMed